Description
CONTOUR NEXT (GLUCOSE) TEST STRIP 50CT (XR423)
First action · last action
2019-09-03 · 2019-09-04
Transactions
2
First transaction's obligation
$486,368
Base + all options value (sum of deltas)
$506,248
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-09-03+$486,368= $486,368
- Mod P000012019-09-04+$19,880= $506,248
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-09-03 | +$486,368 | $486,368 | CONTOUR NEXT (GLUCOSE) TEST STRIP 50CT (XR423) |
| Mod P00001· FUNDING ONLY ACTION | 2019-09-04 | +$19,880 | $506,248 | CONTOUR NEXT (GLUCOSE) TEST STRIP 50CT (XR423) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PX72BSBQTKJ3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77024P0197 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $193,112 | FY2024 |
| 36C77021P0530 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $37,080 | FY2021 |
| 36C77020P0981 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2020 |
| 36C77020P0750 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $70,886 | FY2020 |
| 36C77020P0656 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $2,711 | FY2020 |
| 36C77020P0630 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $35,110 | FY2020 |
Other recipients under 6515 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026N0048 | MERZ PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (36C770) | $236,612 | FY2026 |
| 36C77026K0041 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $993,585 | FY2026 |
| 36C77026P0104 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $17,964 | FY2026 |
| 36C77026F0045 | ATOS MEDICAL INC | NATIONAL CMOP OFFICE (36C770) | $513,331 | FY2026 |
| 36C77026K0040 | ALPHAPOINTE | NATIONAL CMOP OFFICE (36C770) | $1,505,645 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77019P1197_3600_-NONE-_-NONE- · retrieved 2026-09-26.